Pharmaceutical affairs law revision came back to old plans.

Published: 2000-10-23 13:35:00

Updated: 2000-10-23 13:35:00

It is very funny to note that the current revision bills of the pharmaceutical affairs law (the substitutive dispensing except the drugs of bio-equivalency tested was prohibited and Injectable drugs were excluded from the separation program) was more or less resembled to those drafted in the 4th ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK